Basil M Hantash
Overview
Explore the profile of Basil M Hantash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Bian J, Hantash B, Albakr L, Hibbs D, Xiang X, et al.
Int J Pharm
. 2021 Jul;
606:120868.
PMID: 34242628
Hyperpigmentation is a common skin condition with serious psychosocial consequences. Decapeptide-12, a novel peptide, has been found to be safer than hydroquinone in reducing melanin content, with efficacy up to...
2.
Teklemariam T, Zhao L, Hantash B
Regen Med
. 2014 Nov;
9(6):775-84.
PMID: 25431913
Aim: To engineer a stable HLA-G molecule and evaluate its immunomodulatory properties in transgenic human dermal fibroblasts (HDFs). Materials & Methods: A mutated HLA-G1 (mHLA-G1) molecule was generated by modifying...
3.
Zhao L, Teklemariam T, Hantash B
Stem Cell Res
. 2014 Sep;
13(2):342-54.
PMID: 25218797
Human embryonic stem cells (hESCs) are capable of extensive self-renewal and expansion and can differentiate into any somatic tissue, making them useful for regenerative medicine applications. Allogeneic transplantation of hESC-derived...
4.
Teklemariam T, Purandare B, Zhao L, Hantash B
Biochem Biophys Res Commun
. 2014 Sep;
452(3):753-9.
PMID: 25204503
Mesenchymal stem cells (MSCs) are immunosuppressive multipotent cells under investigation for potential therapeutic applications in regenerative medicine and prevention of graft-versus-host disease. Human leukocyte antigen (HLA)-G contributes to the immunomodulatory...
5.
Gadkari R, Zhao L, Teklemariam T, Hantash B
Regen Med
. 2014 Aug;
9(4):453-65.
PMID: 25159063
Aim: To enumerate and characterize mesenchymal stem cells (MSC) derived from human embryonic stem cells (hESC) for clinical application. Materials & Methods: hESC were differentiated into hESC-MSC and characterized by...
6.
Ubeid A, Hantash B
Curr Top Med Chem
. 2014 Jun;
14(12):1418-24.
PMID: 24894693
Short sequence amino acids or oligopeptides have recently garnered attention for use as treatments for a myriad of dermatologic disorders due to their ability to effect and modulate various biological...
7.
Ubeid A, Hantash B
Curr Top Med Chem
. 2014 May;
14(12):1463-8.
PMID: 24853563
Melanoma incidence continues to rise due to intentional exposure to ultraviolet radiation (UVR) from sunlight and indoor tanning beds. Eumelanin exhibits photoprotective effects; thus, agents that induce its synthesis offer...
8.
Jow T, Hantash B
Dermatitis
. 2014 Jan;
25(1):e1-5.
PMID: 24407054
Melasma is an acquired cutaneous disorder caused by an overproduction of melanin by the enzyme tyrosinase. Melasma remains a therapeutic challenge and no definitive standard therapy exists. Although hydroquinone (HQ)...
9.
Bhatia A, Hsu J, Hantash B
J Drugs Dermatol
. 2014 Jan;
13(1):84-5.
PMID: 24385124
No abstract available.
10.
Zhao L, Teklemariam T, Hantash B
Cell Immunol
. 2013 Dec;
287(1):23-6.
PMID: 24355712
HLA-G plays an important role in the induction of immune tolerance. Various attempts to produce good manufacturing practice levels of HLA-G as a therapeutic molecule have failed to date partly...